Locations:
Search
Once-promising HDL-targeted therapy fails to show plaque regression
GLAGOV results boost hopes for coming outcome trials
Enhanced protocols and more research warranted
Study reveals a way to predict recovery in the long term
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Celecoxib is noninferior to naproxen and ibuprofen in cardiac safety
AHA/ACC recommendations address broader spectrum of PAD care
Online calculator makes improved prediction available to all
Pioneer of angioplasty never stopped innovating and teaching
A novel endovascular navigation technology in action
Study raises prospect of a nutritional adjunct for curbing CV risk
Advertisement
Advertisement